PD-1 blockade combined with gemcitabine plus nab-paclitaxel is superior to chemotherapy alone in the management of unresectable stage III/IV pancreatic cancer: a retrospective real-world study

BACKGROUND: Pancreatic cancer (PC) is widely recognized as one of the most malignant forms of cancer worldwide. Monotherapy with immune checkpoint inhibitors (ICI) has shown limited efficacy in treating this disease. There was controversy surrounding whether combining ICI with chemotherapy provided...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Daoan, Hu, Jing, Wu, Xiaoyu, Wang, Banglu, Chen, Rui, Zhao, Weiqing, Fang, Cheng, Ji, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641475/
https://www.ncbi.nlm.nih.gov/pubmed/37965469
http://dx.doi.org/10.3389/fonc.2023.1281545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641475/
https://www.ncbi.nlm.nih.gov/pubmed/37965469
http://dx.doi.org/10.3389/fonc.2023.1281545

Ejemplares similares